Recursion Pharmaceuticals
RXRX
$8.28
Share price
-6.65%
Change (1 day)
-5.59%
Change (1 year)
Categories
Recursion Pharmaceuticals (RXRX) - Cash on Hand
Cash on Hand as of March 2024 : $0.29 B
According to Recursion Pharmaceuticals's latest financial reports the company has $0.29 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Recursion Pharmaceuticals - Cash on Hand chart (from 2020 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.39 B | -28.79% |
| 2022-12-31 | $0.54 B | 6.46% |
| 2021-12-31 | $0.51 B | 97.07% |
| 2020-12-31 | $0.26 B | 275.09% |
| 2019-12-31 | $69.88 M |